FTAC ZEUS ACQUISITION CORP. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
Assets
Current assets
Cash
Prepaid expenses
Total Current Assets
Reimbursement receivable
Reimbursement receivable
Investments held in Trust Account
Total Assets
Accounts payable and accrued expenses
Current liabilities
Accounts payable and accrued expenses
Income taxes payable
Due to related party
Promissory note – related party
Total current liabilities
Deferred underwriting fee payable
Deferred advisory fees
Total liabilities
Class A common stock subject to possible redemption, $0.0001 par value; 40,250,000 issued and outstanding shares at a redemption value of $10.15 per share as of March 31, 2022 and December 31, 2021
Class A common stock subject to possible redemption, $0.0001 par value; 40,250,000 issued and outstanding shares at a redemption value of $10.44 and $10.26 per share as of June 30, 2023 and December 31, 2022, respectively
Stockholders’ Deficit:
Class A common stock, $0.0001 par value; 150,000,000 shares authorized; 1,778,750 shares issued and outstanding (excluding 40,250,000 shares subject to possible redemption) as of March 31, 2022 and December 31, 2021
Class A common stock, $0.0001 par value; 90,000,000 shares authorized; 1,778,750 shares issued and outstanding (excluding 40,250,000 shares subject to possible redemption) as of March 31, 2023 and December 31, 2022
Class A common stock, $0.0001 par value; 90,000,000 shares authorized; 1,778,750 shares issued and outstanding (excluding 40,250,000 shares subject to possible redemption) as of June 30, 2023 and December 31, 2022
Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 14,009,583 shares issued and outstanding as of June 30, 2023 and December 31, 2022
Accumulated deficit
Total Stockholders’ Deficit
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit

Comments